Cumberland Pharma (CPIX)
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. Th...
- Open
- 7.670
- High
- 8.000
- Low
- 7.510
- Prev. Close
- 7.650
- Volume
- 25.77K
- Turnover
- 200.05K
- Avg Price
- 7.764
- Bid/Ask Ratio
- -98.02%
- Amplitude
- 6.41%
- 52wk High
- 8.450
- Volume Ratio
- 0.10
- Turnover Ratio
- 0.29%
Cumberland Pharma Analyst Rating
View moreForecast & Rating
Aug 16, 2021Price forecast
$8.508.42%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · Aug 11 at 03:09 AM
Biotech Stocks At 52-Week Highs - SLN +29% & ABCL +34% On Positive Trial Data, CPIX, CLDX, BDSX
- TradingView · Aug 7 at 04:21 PM
CUMBERLAND PHARMACEUTICALS INC 2026: Revenue $166.46K, EPS ($0.29) — 10-Q Summary
- Simplywall · Aug 6 at 03:21 AM
Cumberland Pharmaceuticals (CPIX) Stock Cools As Cash Rich Biotech Pivot Begins
- Earnings Watch · Aug 4 at 04:57 PM
Cumberland Pharma | 8-K: FY2026 Q2 Revenue: USD 166.46 K
- PUBT · Aug 4 at 04:47 PM
Cumberland Pharmaceuticals Q2 FY26 net loss widens to USD 4.1 million; revenue falls 56.28% to USD 166,458
- prnewswire · Aug 4 at 04:06 PM
17:06 ETCUMBERLAND PHARMACEUTICALS REPORTS COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
